inositol has been researched along with Anxiety Neuroses in 6 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study is a meta-analysis of inositol as a treatment for depression and anxiety disorders." | 8.90 | A meta-analysis of inositol for depression and anxiety disorders. ( Iwata, N; Kishi, T; Matsuda, Y; Mukai, T, 2014) |
| "This study is a meta-analysis of inositol as a treatment for depression and anxiety disorders." | 4.90 | A meta-analysis of inositol for depression and anxiety disorders. ( Iwata, N; Kishi, T; Matsuda, Y; Mukai, T, 2014) |
| "Mood disorders and Major Depressive Disorder, in particular, appear to be some of the most common psychiatric disorders with a high rate of comorbidity most frequently of anxiety or substance abuse disorders (alcohol use disorder)." | 2.66 | Immunological Disturbances and Neuroimaging Findings in Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD) Comorbid Patients. ( Kakanakova, A; Maes, M; Popov, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kakanakova, A | 1 |
| Popov, S | 1 |
| Maes, M | 1 |
| Strawn, JR | 1 |
| Chu, WJ | 1 |
| Whitsel, RM | 1 |
| Weber, WA | 1 |
| Norris, MM | 1 |
| Adler, CM | 1 |
| Eliassen, JC | 1 |
| Phan, KL | 1 |
| Strakowski, SM | 1 |
| DelBello, MP | 1 |
| Mukai, T | 1 |
| Kishi, T | 1 |
| Matsuda, Y | 1 |
| Iwata, N | 1 |
| Kinrys, G | 1 |
| Coleman, E | 1 |
| Rothstein, E | 1 |
| Parikh, SV | 1 |
| LeBlanc, SR | 1 |
| Ovanessian, MM | 1 |
| Zhang, Y | 1 |
| Filiou, MD | 1 |
| Reckow, S | 1 |
| Gormanns, P | 1 |
| Maccarrone, G | 1 |
| Kessler, MS | 1 |
| Frank, E | 1 |
| Hambsch, B | 1 |
| Holsboer, F | 1 |
| Landgraf, R | 1 |
| Turck, CW | 1 |
3 reviews available for inositol and Anxiety Neuroses
| Article | Year |
|---|---|
Immunological Disturbances and Neuroimaging Findings in Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD) Comorbid Patients.
Topics: Alcoholism; Anxiety Disorders; Brain; Comorbidity; Cytokines; Depressive Disorder, Major; gamma-Amin | 2020 |
A meta-analysis of inositol for depression and anxiety disorders.
Topics: Anxiety Disorders; Depressive Disorder; Humans; Inositol; Randomized Controlled Trials as Topic; Tre | 2014 |
Natural remedies for anxiety disorders: potential use and clinical applications.
Topics: Anti-Anxiety Agents; Antioxidants; Anxiety Disorders; Humans; Hypericum; Inositol; Kava; Melatonin; | 2009 |
3 other studies available for inositol and Anxiety Neuroses
| Article | Year |
|---|---|
A pilot study of anterior cingulate cortex neurochemistry in adolescents with generalized anxiety disorder.
Topics: Adolescent; Anxiety Disorders; Aspartic Acid; Brain Chemistry; Case-Control Studies; Child; Creatine | 2013 |
Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; | 2010 |
Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways.
Topics: Amino Acid Sequence; Animals; Anxiety Disorders; Biomarkers; Carbonic Anhydrase II; Glutamic Acid; H | 2011 |